Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Roles of LINC01473 and CD74 in osteoblasts in multiple myeloma bone disease.
Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research
Published: January 06, 2022
Complement C3a activates osteoclasts by regulating the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma.
Journal: Cancer biology & medicine
Published: May 07, 2021
Infection risk in autoimmune hematological disorders with low-dose rituximab treatment.
Journal: Journal of clinical laboratory analysis
Published: March 13, 2020
CCN1 stimulated the osteoblasts via PTEN/AKT/GSK3β/cyclinD1 signal pathway in Myeloma Bone Disease.
Journal: Cancer medicine
Published: May 20, 2019
Involvement of MM cell-derived exosomes in T lymphocytes immune responses.
Journal: Oncology letters
Published: May 12, 2019
Deficient invariant natural killer T cells had impaired regulation on osteoclastogenesis in myeloma bone disease.
Journal: Journal of cellular and molecular medicine
Published: September 17, 2017
A monocentric retrospective study comparing pulse cyclophosphamide therapy versus low dose rituximab in the treatment of refractory autoimmune hemolytic anemia in adults.
Journal: International journal of hematology
Published: February 14, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026